NDC Package 69683-202-11 Dermoscribe Seborrheic Dermatitis

Sulfur,Salicylic Acid,Hydrocortisone Cream Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69683-202-11
Package Description:
60 g in 1 BOTTLE
Product Code:
Proprietary Name:
Dermoscribe Seborrheic Dermatitis
Non-Proprietary Name:
Sulfur, Salicylic Acid, Hydrocortisone
Substance Name:
Hydrocortisone; Salicylic Acid; Sulfur
Usage Information:
For use only by persons over 12 years old. Apply in a thin layer over the affected area once or twice daily as required.Use only in accordance with the directions on the label and within the packaging. Refer to enclosed leaflet for detailed directions.
11-Digit NDC Billing Format:
69683020211
NDC to RxNorm Crosswalk:
  • RxCUI: 1738574 - hydrocortisone 1 % / salicylic acid 3 % / sulfur 3 % Topical Cream
  • RxCUI: 1738574 - hydrocortisone 10 MG/ML / salicylic acid 30 MG/ML / sulfur 30 MG/ML Topical Cream
  • Product Type:
    Human Otc Drug
    Labeler Name:
    Dermoscribe Pty Ltd
    Dosage Form:
    Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Sample Package:
    No
    FDA Application Number:
    part348
    Marketing Category:
    OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
    Start Marketing Date:
    03-23-2015
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69683-202-11?

    The NDC Packaged Code 69683-202-11 is assigned to a package of 60 g in 1 bottle of Dermoscribe Seborrheic Dermatitis, a human over the counter drug labeled by Dermoscribe Pty Ltd. The product's dosage form is cream and is administered via topical form.

    Is NDC 69683-202 included in the NDC Directory?

    Yes, Dermoscribe Seborrheic Dermatitis with product code 69683-202 is active and included in the NDC Directory. The product was first marketed by Dermoscribe Pty Ltd on March 23, 2015 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 69683-202-11?

    The 11-digit format is 69683020211. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-269683-202-115-4-269683-0202-11